Results 261 to 270 of about 1,044,515 (400)

Chitosan nanoparticles with aluminium hydroxide gel as nasal delivery system for influenza vaccine

, 2012
Anawatch Mitpratan
openalex   +1 more source

Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies

European Journal of Haematology, EarlyView.
ABSTRACT Infections remain a leading cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL), reflecting both intrinsic immune dysfunction and therapy‐related immunosuppression. The pathogenesis of immunodeficiency in CLL is multifactorial: neoplastic B cells impair humoral immunity, T cells are functionally exhausted, and ...
Enrica Antonia Martino, Santino Caserta, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Fortunato Morabito, Massimo Gentile   +10 more
wiley   +1 more source

Limited Predictive Utility of Baseline Peripheral Blood Bulk Transcriptomics for Influenza Vaccine Responsiveness in Older Adults. [PDF]

Vaccines (Basel)
Boissiere-O'Neill T, Srihari S, Macia L.
europepmc   +1 more source

Factors Affecting Immune Reconstitution Post‐Allogeneic HSCT in Children: The Case for an Individualized Approach to Vaccination

European Journal of Haematology, EarlyView.
ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is increasingly used to treat malignant and non‐malignant diseases. Following allogeneic HSCT, patients are particularly vulnerable to vaccine‐preventable diseases (VPD) because conditioning depletes immune cells, including memory cells.
Hélène Buvelot, Frederic Baleydier, Laure Pittet, Geraldine Blanchard‐Rohner   +3 more
wiley   +1 more source

Seasonal influenza vaccine knowledge and attitudes among pregnant women: a cross-sectional study in Palestine. [PDF]

BMC Public Health
Almahmoud OH, Takrouri S, Khalaileh H, Joulani S, Khawaja A.   +4 more
europepmc   +1 more source

Investigation of Influenza A(H5N1) Virus Neutralization by Quadrivalent Seasonal Vaccines, United Kingdom, 2021–2024

Phoebe Stevenson-Leggett, Lorin Adams, David Greenwood, Abi Lofts, Vincenzo Libri, Bryan Williams, Sonia Gandhi, Charles Swanton, S.J. Gamblin, Edward J Carr, Ruth Harvey, Nicola S. Lewis, Mary Wu, Emma Wall, Legacy Investigators   +14 more
openalex   +1 more source

Bacterially Produced Recombinant Influenza Vaccines Based on Virus-Like Particles

, 2013
Andrea Jegerlehner, Franziska Zabel, Alice Langer, Klaus Dietmeier, Gary T. Jennings, Philippe Saudan, Martin F. Bachmann   +6 more
openalex   +2 more sources

A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients

Clinical Infectious Diseases, 2018
Y. Natori, Mika Shiotsuka, Jaclyn Slomovic, K. Hoschler, V. Ferreira, P. Ashton, C. Rotstein, L. Lilly, J. Schiff, L. Singer, A. Humar, Deepali Kumar   +11 more
semanticscholar   +1 more source

Molecular detection of pathogens in an equine fever diagnostic panel: 2019–2023

Equine Veterinary Journal, EarlyView.
Abstract Background A common diagnostic approach for febrile horses is to test for a panel of potential pathogens. Panels are curated by expert opinion and vary between diagnostic laboratories. Objectives To report the results of a newly developed equine fever diagnostic panel (EFDP) between 2019 and 2023 and evaluate the frequency of positive results.
Toby L. Pinn‐Woodcock, Melissa S. Aprea, Manigandan Lejeune, Joy E. Tomlinson   +3 more
wiley   +1 more source

Establishment of Canine RNA Polymerase I-Driven Reverse Genetics for Influenza A Virus: Its Application for H5N1 Vaccine Production

, 2007
Shin Murakami, Taisuke Horimoto, S. Yamada, Satoshi Kakugawa, Hideo Goto, Yoshihiro Kawaoka   +5 more
openalex   +1 more source